Evidence map›Paper›PMID 33264634›Full record

ArticleExperimental neurology2021

Extracellular vesicles derived from bone marrow mesenchymal stem cells enhance myelin maintenance after cortical injury in aged rhesus monkeys.

Veronica Go, Deniz Sarikaya, Yuxin Zhou, Bethany G E Bowley, Monica A Pessina, Douglas L Rosene, Zheng Gang Zhang, Michael Chopp, Seth P Finklestein, Maria Medalla and 2 more

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Veronica GoDepartment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, United States. Electronic address: vgo@bu.edu.
Deniz SarikayaResearch Center for Translational Medicine, Koç University School of Medicine, Turkey.
Yuxin ZhouDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States.
Bethany G E BowleyDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States.
Monica A PessinaDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States.
Douglas L RoseneDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States; Yerkes National Primate Research Center, Emory University, United States; Center for Systems Neuroscience, Boston University, United States.
Zheng Gang ZhangDepartment of Neurology, Henry Ford Health Systems, United States.
Michael ChoppDepartment of Neurology, Henry Ford Health Systems, United States; Department of Physics, Oakland University, United States.
Seth P FinklesteinDepartment of Neurology, Massachusetts General Hospital, United States; Stemetix, Inc., United States.
Maria MedallaDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States; Center for Systems Neuroscience, Boston University, United States.
Benjamin BullerDepartment of Neurology, Henry Ford Health Systems, United States.
Tara L MooreDepartment of Anatomy & Neurobiology, Boston University School of Medicine, United States; Center for Systems Neuroscience, Boston University, United States.
Boston University · USHenry Ford Health System · USKoç University · TRMassachusetts General Hospital · USOakland University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Age-related cognitive decline and myelin pathology: A comprehensive study of oligodendroglia, microglia and myelin homeostasis in the normal aging monkeyRF1AG062831 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2019 to 2019
$3.7M
Mechanisms of myelin damage and cognitive impairment in the aging monkey: Gene Expression, Neurophysiology, Inflammation and Effects of Calorie RestrictionRF1AG043640 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2019 to 2019
$3.7M
Mechanisms underlying extracellular vesicle mediated changes in inflammation, neural circuitry and plasticity following cortical injury in aged monkeysR01AG078460 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI TARA L MOORE, Maria Medalla · 2022 to 2026
$3.2M
Histopathology, Neuroimaging and Mechanism of Myelin Damage in Aging Monkey BrainR01AG043640 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2013 to 2017
$3.0M
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of StU01NS076474 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2014 to 2017
$1.8M
Exosomes from bone marrow-derived mesenchymal stem cells as a restorative treatment in a non-human primate model of cerebral injuryR21NS102991 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOORE, TARA L · 2017 to 2018
$465k
Recovery of Motor Function Impaired by Cortical Injury: An Exploratory Comparison of the Influences of Four Different Post-injury Treatments on Processes Affecting NeuroplasticityR21NS111174 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOORE, TARA L, ROSENE, DOUGLAS L · 2019 to 2019
$454k
NCATS NIH HHS UL1 TR001430NIA NIH HHS R01 AG043640NIA NIH HHS R01 AG078460NIA NIH HHS RF1 AG043640NIA NIH HHS RF1 AG062831NINDS NIH HHS R21 NS102991NINDS NIH HHS R21 NS111174NINDS NIH HHS U01 NS076474
6 · The paper itself

Abstract

Cortical injury, such as stroke, causes neurotoxic cascades that lead to rapid death and/or damage to neurons and glia. Axonal and myelin damage in particular, are critical factors that lead to neuronal dysfunction and impair recovery of function after injury. These factors can be exacerbated in the aged brain where white matter damage is prevalent. Therapies that can ameliorate myelin damage and promote repair by targeting oligodendroglia, the cells that produce and maintain myelin, may facilitate recovery after injury, especially in the aged brain where these processes are already compromised. We previously reported that a novel therapeutic, Mesenchymal Stem Cell derived extracellular vesicles (MSC-EVs), administered intravenously at both 24 h and 14 days after cortical injury, reduced microgliosis (Go et al. 2019), reduced neuronal pathology (Medalla et al. 2020), and improved motor recovery (Moore et al. 2019) in aged female rhesus monkeys. Here, we evaluated the effect of MSC-EV treatment on changes in oligodendrocyte maturation and associated myelin markers in the sublesional white matter using immunohistochemistry, confocal microscopy, stereology, qRT-PCR, and ELISA. Compared to vehicle control monkeys, EV-treated monkeys showed a reduction in the density of damaged oligodendrocytes. Further, EV-treatment was associated with enhanced myelin maintenance, evidenced by upregulation of myelin-related genes and increases in actively myelinating oligodendrocytes in sublesional white matter. These changes in myelination correlate with the rate of motor recovery, suggesting that improved myelin maintenance facilitates this recovery. Overall, our results suggest that EVs act on oligodendrocytes to support myelination and improves functional recovery after injury in the aged brain. SIGNIFICANCE: We previously reported that EVs facilitate recovery of function after cortical injury in the aged monkey brain, while also reducing neuronal pathology (Medalla et al. 2020) and microgliosis (Go et al. 2019). However, the effect of injury and EVs on oligodendrocytes and myelination has not been characterized in the primate brain (Dewar et al. 1999; Sozmen et al. 2012; Zhang et al. 2013). In the present study, we assessed changes in myelination after cortical injury in aged monkeys. Our results show, for the first time, that MSC-EVs support recovery of function after cortical injury by enhancing myelin maintenance in the aged primate brain.

Indexed as

Bone Marrow CellsExtracellular VesiclesMyelin SheathAgingAnimalsBrain InjuriesCerebral CortexFemaleGliosisMacaca mulattaMesenchymal Stem Cell TransplantationMovement DisordersOligodendrogliaRecovery of FunctionWhite MatterAgingCortical injuryExtracellular vesiclesMonkeysMyelinNon-human primatesOligodendrocytesStrokeWhite matter

Identifiers

PMID33264634
PMCPMC7946396
OpenAlexW3108226754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.